Search
Friday 17 July 2015
  • :
  • :
Latest Update

Pre-Market News Buzz on: Phillips 66 (NYSE:PSX), Oncolytics Biotech, (NASDAQ:ONCY), Orchid Island Capital (NYSE:ORC), LinnCo (NASDAQ:LNCO)

On Monday, Phillips 66 (NYSE:PSX)’s shares inclined 2.34% to $83.40.

The board of directors of Phillips 66 (PSX) has declared a quarterly dividend of 56 cents per share on Phillips 66 common stock. The dividend is payable on Sept. 1, 2015, to shareholders of record as of the close of business on Aug. 17, 2015.

Phillips 66 operates as an energy manufacturing and logistics company. It operates through four segments: Midstream, Chemicals, Refining, and Marketing and Specialties (M&S). The Midstream segment transports crude oil and other feedstocks to its refineries and other locations; and delivers refined and specialty products, in addition to provides storage services for crude oil and petroleum products. This segment also gathers, processes, transports, and markets natural gas; and transports, fractionates, and markets natural gas liquids in the United States.

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY)’s shares gained 26.34% to $0.732.

Oncolytics Biotech® Inc. (ONCY) declared that Dr. Devalingam Mahalingam of the Cancer Therapy and Research Centre, University of Texas Health Science Centre San Antonio, made a poster presentation at the ESMO World Congress on Gastrointestinal Cancer. The poster, titled “Oncolytic Virus Therapy in Pancreatic Cancer: Clinical Efficacy and Pharmacodynamic Analysis of REOLYSIN® in Combination with Gemcitabine in Patients with Advanced Pancreatic Adenocarcinoma,” covers final results from the Company’s REO 017 Phase 2 study.

Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOLYSIN, a cancer therapeutic that is in various clinical trials for human use. Its cancer product is a potential therapeutic for tumours possessing an activated Ras pathway.

At the end of Monday’s trade, Orchid Island Capital Inc (NYSE:ORC)‘s shares dipped -7.79% to $8.76.

Orchid Island Capital, Inc. (ORC) declared that the Board of Directors declared a monthly cash dividend for the month of July 2015. The dividend of $0.14 per share will be paid July 31, 2015, to holders of record on July 27, 2015, with an ex-dividend date of July 23, 2015.

Orchid Island Capital, Inc., a specialty finance company, invests in residential mortgage-backed securities (RMBS) in the United States. The company’s RMBS are backed primarily by single-family residential mortgage loans, referred as Agency RMBS.

LinnCo LLC (NASDAQ:LNCO), ended its Monday’s trading session with -7.70% loss, and closed at $8.21.

LINN Energy, LLC (LINE) and LinnCo, LLC (LNCO) declared that LINN has signed a formal agreement with private capital investor GSO Capital Partners L.P. (“GSO”), the credit platform of The Blackstone Group L.P. (BX) (“Blackstone”), to fund oil and natural gas development (the “DrillCo Agreement”).

Funds managed by GSO and its associates have agreed to commit up to $500 million with 5-year availability to fund drilling programs on locations offered by LINN. Subject to adjustments depending on asset characteristics and return expectations of the selected drilling plan, GSO will fund 100 percent of the costs associated with new wells drilled under the DrillCo Agreement and is predictable to receive an 85 percent working interest in these wells until it achieves a 15 percent internal rate of return on annual groupings of wells, while LINN is predictable to receive a 15 percent carried working interest during this period. Upon reaching the internal rate of return target, GSO’s interest will be reduced to 5 percent, while LINN’s will enhance to 95 percent.

LinnCo, LLC, through its limited liability company interests in Linn Energy, LLC, focuses on the acquisition and development of oil and natural gas properties in the United States. The company was founded in 2012 and is headquartered in Houston, Texas.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *